Scot Harper
Director Técnico/Científico/I+D en RADIOPHARM THERANOSTICS LIMITED .
Cargos activos de Scot Harper
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Director Técnico/Científico/I+D | 01/12/2021 | - |
Historial de carrera de Scot Harper
Antiguos cargos conocidos de Scot Harper.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENDOCYTE, INC. | Director Técnico/Científico/I+D | 07/05/2013 | 28/10/2016 |
| Corporate Officer/Principal | 07/05/2013 | 14/05/2014 |
Formación de Scot Harper.
| University of South Alabama | Graduate Degree |
| DePauw University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Australia | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Empresas privadas | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Bolsa de valores
- Insiders
- Scot Harper
- Experiencia
